Premier Inc. (PINC), a leading healthcare improvement company, today released updated inflation estimates for contracted and non-contracted pharmaceutical pricing for fiscal year 2020 (July 2019 – June 2020), projecting a 4.2 percent increase in total pharmaceutical costs for non-disproportionate share (DSH) hospitals and 3.8 percent for DSH-eligible facilities. This 4.2 percent inflation rate is approximately 0.4 percent higher than previous projections. The majority of the overall pharmaceutical inflation comes from new drugs (2.8 percent), including cellular and gene therapies.

source https://finance.yahoo.com/news/premier-inc-projects-4-2-120400839.html?.tsrc=rss